Примери за използване на Clinical outcomes на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
as well as improved understanding of research targets and clinical outcomes.
Patients with infections brought about by drug-resistant bacteria tend to have worse clinical outcomes and an increased risk of death.
Rationale: to investigate the effect of obeticholic acid on clinical outcomes in subjects with PBC.
can lead to more consistent and predictable clinical outcomes.
evidence-based protocols that reduce preventable patient harm and improve clinical outcomes.
Patients with infections caused by drug-resistant bacteria are at risk of worse clinical outcomes and death.
lack of benefit on clinical outcomes, and atrial fibrillation.
At week 54, the clinical outcomes observed in these patients were similar to the clinical outcomes reported for the patients achieving clinical response at week 6.
There were too few patients≥65 years of age enrolled in the controlled clinical trials to draw meaningful conclusions about the effects of age on clinical outcomes.
as well as improved understanding of research targets and clinical outcomes.
However, it has never been demonstrated that a small increase in total ICS dose would have an impact on the lung function or on the clinical outcomes.
Healthgrouper is a platform for sharing knowledge on a higher quality clinical outcomes and better patient care experiences in the region of South Eastern Europe.
current consensus guidelines and to improve patients' clinical outcomes.
The first generation of biologics to hit the market about 15 years ago led to improved clinical outcomes in the treatment of psoriasis.
the pharmaceutical industry and ensures that clinical outcomes, prescribing habits,
The clinical outcomes have been scientifically proven by over 20 peer-reviewed articles
Patients with infections caused by drug-resistant bacteria are at increased risk of worse clinical outcomes and death, and consume more health care resources than patients infected with non-resistant strains of the same bacteria.
A better understanding of the molecular reasons why some patients do not respond to immune checkpoint inhibitors could identify new therapeutic targets for combination treatments that may improve clinical outcomes.
assess the impact of continued viral negativity on clinical outcomes.
Longer term data are not currently available to show whether long-term therapy with Jinarc continues to slow the rate of renal function decline and affect clinical outcomes of ADPKD, including delay in the onset of end-stage renal disease.